Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
17 studies found for:    Open Studies | "Carcinoma, Small Cell"

Modify this search | How to Use Search Results

Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Cancel
Rank Status Study
1 Recruiting Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
Conditions: Non-Small Cell Lung Cancer;   Small Cell Lung Cancer;   Extrapulmonary Small Cell Cancer;   Pulmonary Neuroendocrine Tumors;   Thymic Epithelial Tumors
Intervention:
2 Recruiting Temozolomide as Maintenance Therapy in Small Cell Lung Cancer
Condition: Carcinoma, Small Cell
Intervention: Drug: Temozolomide
3 Unknown † Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient
Condition: Carcinoma, Small Cell
Interventions: Drug: Belotecan/Cisplatin;   Drug: Etoposide/Cisplatin
4 Recruiting Neurocognitive Function After Prophylactic Cranial Irradiation & Hippocampal Sparing in LD SCLC Patients - a Pilot Study
Condition: Carcinoma, Small Cell
Intervention: Radiation: Whole brain radiotherapy with reduced dose to the hippocampi
5 Recruiting Metabolomic Analysis of Lung Cancer
Conditions: Carcinoma, Non-Small Cell Lung;   Carcinoma, Small Cell Lung
Intervention: Other: 13-C-glucose
6 Unknown † N-AcetylCysteine vs. Placebo to Prevent Neurotoxicity Induced by Platinum Containing Chemotherapy
Conditions: Carcinoma, Non-Small-Cell Lung;   Carcinoma, Small Cell Lung;   Mesothelioma
Interventions: Drug: N-Acetylcysteine;   Drug: Placebo
7 Recruiting Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies
Conditions: Carcinoma, Non-Small-Cell Lung;   Carcinoma, Small Cell Lung;   Carcinoma, Thymic
Interventions: Drug: AZD6244;   Drug: MK-2206;   Drug: Lapatinib;   Drug: Erlotinib;   Drug: Sunitinib;   Procedure: Molecular Profiling
8 Recruiting ADXS11-001 High Dose HPV+ Cervical Cancer
Conditions: Effects of Immunotherapy;   Metastatic/Recurrent Cervical Cancer;   Cervical Adenocarcinoma;   Cervical Adenosquamous Cell Carcinoma;   Cervical Squamous Cell Carcinoma;   Cervical Small Cell Carcinoma;   Stage III Cervical Cancer;   Stage IVA Cervical Cancer;   Stage IVB Cervical Cancer
Intervention: Biological: ADXS11-001
9 Unknown † Study of Relationship Between UGT1A1 Gene Polymorphism and Toxicity and Efficacy of Irinotecan in Small Cell Lung Cancer
Condition: Small Cell Carcinoma of Lung
Intervention: Drug: Irinotecan
10 Recruiting Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium
Condition: Bladder Cancer
Interventions: Radiation: Prophylactic Cranial Irradiation (PCI);   Other: Brain X-ray
11 Recruiting International Ovarian & Testicular Stromal Tumor Registry
Conditions: Ovarian Stromal Tumor;   Testicular Stromal Tumors;   Ovarian Small Cell Carcinoma
Intervention:
12 Recruiting Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Carcinoma;   Cervical Small Cell Carcinoma;   Cervical Squamous Cell Carcinoma;   Recurrent Cervical Carcinoma;   Stage III Cervical Cancer;   Stage IVA Cervical Cancer;   Stage IVB Cervical Cancer
Interventions: Biological: Attenuated Live Listeria Encoding HPV 16 E7 Vaccine ADXS11-001;   Other: Laboratory Biomarker Analysis
13 Recruiting A Pilot Study Treatment of Malignant Tumors Using [18F] Fluorodeoxyglucose (FDG)
Condition: Stage IV Radiosensitive Tumors With High FDG Uptake (i.e. Small Cell Carcinomas of the Lung, Lymphomas, Etc) Not Responding to Standard of Care
Intervention: Radiation: FDG
14 Unknown † Biweekly Gemcitabine and Docetaxel as First Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Gemcitabine and Docetaxel
15 Recruiting Small Cell Cervix Survey
Condition: Cervical Cancer
Intervention: Behavioral: Questionnaires
16 Unknown † Panitumumab, Cisplatin, and Pelvic Radiation Therapy in Treating Patients With Stage IB, Stage II, or Stage III Cervical Cancer
Condition: Cervical Cancer
Interventions: Biological: panitumumab;   Drug: cisplatin;   Radiation: brachytherapy;   Radiation: external beam radiation therapy
17 Unknown † Collecting Tumor Samples From Patients With Gynecological Tumors
Condition: Cancer
Intervention: Other: biologic sample preservation procedure
To Top

† Indicates status has not been verified in more than two years